Literature DB >> 15095329

Facemasks and facial deposition of aerosols.

Sanjay Sangwan1, Burak K Gurses, Gerald C Smaldone.   

Abstract

Passage of aerosol around or through a facemask can result in deposition on the face and in the eyes. The present study quantified facial and eye deposition in a model simulating drug delivery to a young child. Aerosol delivery and facial deposition of radiolabeled saline test aerosols were studied in vitro with filters and a gamma camera. A child's face facsimile, attached to a piston pump, was used to simulate the patient receiving aerosol therapy. A filter placed in the oropharynx of the face facsimile measured aerosol delivery (inhaled mass). Seven commercially available facemasks in combination with three jet nebulizers were studied for aerosol delivery to the "patient" as well as for deposition on the face and in the eyes. Inhaled mass varied from 2.24-5.96% of nebulizer charge (drug placed in the nebulizer). Facial deposition varied from 0.44-2.34% of nebulizer charge, with eye deposition at 0.09-1.78%. All facemasks leaked aerosol, with significant facial and eye deposition approaching in magnitude delivery to the lung. Factors affecting facial and eye deposition include the interactive design characteristics of the facemask and nebulizer, as well as the aerodynamic properties of the aerosol. Copyright 2004 Wiely-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095329     DOI: 10.1002/ppul.10454

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  8 in total

1.  Inhalation devices.

Authors: 
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

Review 2.  A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

Authors:  Arzu Ari
Journal:  Ann Transl Med       Date:  2021-04

3.  Improving the lung delivery of nasally administered aerosols during noninvasive ventilation-an application of enhanced condensational growth (ECG).

Authors:  P Worth Longest; Geng Tian; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2011-03-16       Impact factor: 2.849

Review 4.  Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.

Authors:  Worth Longest; Benjamin Spence; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-07-09       Impact factor: 2.849

5.  Improving pharmaceutical aerosol delivery during noninvasive ventilation: effects of streamlined components.

Authors:  P Worth Longest; Laleh Golshahi; Michael Hindle
Journal:  Ann Biomed Eng       Date:  2013-02-20       Impact factor: 3.934

Review 6.  Drug delivery interfaces: A way to optimize inhalation therapy in spontaneously breathing children.

Authors:  Arzu Ari
Journal:  World J Clin Pediatr       Date:  2016-08-08

7.  Patients' practices and experiences of using nebuliser therapy in the management of COPD at home.

Authors:  B Alhaddad; F J Smith; T Robertson; G Watman; K M G Taylor
Journal:  BMJ Open Respir Res       Date:  2015-02-24

8.  The challenge of delivering therapeutic aerosols to asthma patients.

Authors:  Federico Lavorini
Journal:  ISRN Allergy       Date:  2013-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.